Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR133a regulates cardiomyocyte hypertrophy in diabetes

10 Dec 2009

Abstract excerpt

BACKGROUND: Diabetic cardiomyopathy, characterized by cardiac hypertrophy and contractile dysfunction, eventually leads to heart failure. We have previously shown that alterations of a number of key molecules are involved in producing cardiomyocyte hypertrophy in diabetes. The aim of the present study was to determine whether microRNAs (miRNA) play a role in mediating altered gene expression and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Function and Risk Factors
Share to Congenital heart defects research
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20013939
DOI: 10.1002/dmrr.1054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR133a regulates cardiomyocyte hypertrophy in diabetesPMID 20013939Read ↗

Role of microRNAs in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic miceSemantic proximity Read ↗

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeuticsSemantic proximity Read ↗

MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathySemantic proximity Read ↗

Molecular Dysfunction and Phenotypic Derangement in Diabetic CardiomyopathySemantic proximity Read ↗

Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathySemantic proximity Read ↗

The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathySemantic proximity Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.Semantic proximity Read ↗

Pathogenesis of Diabetic Cardiomyopathy and Role of miRNASemantic proximity Read ↗

Molecular Mechanisms and Epigenetic Regulation in Diabetic CardiomyopathySemantic proximity Read ↗

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.